Herpetic esophagitis following bendamustine-containing regimen
Hiromichi Yamane,1 Yasumasa Monobe,2 Tomohiro Tanikawa,3 Nobuaki Ochi,1 Yoshihiro Honda,1 Hirofumi Kawamoto,3 Nagio Takigawa1 1Department of General Internal Medicine 4, 2Department of Pathology, 3Department of General Internal Medicine 2, Kawasaki Medical School, Kita-ku, Okayama, Japan Abstract:...
Main Authors: | Yamane H, Monobe Y, Tanikawa T, Ochi N, Honda Y, Kawamoto H, Takigawa N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/herpetic-esophagitis-following-bendamustine-containing-regimen-peer-reviewed-article-TCRM |
Similar Items
-
Encephalopathy after Bendamustine Treatment: A Rare Side Effect?
by: Carolina Amado, et al.
Published: (2020-11-01) -
Bendamustine in the treatment of B-cell non-Hodgkin lymphoma
by: L G Babicheva, et al.
Published: (2018-12-01) -
Experience with the use of bendamustine (Rozustin®): safety and efficacy
by: A. A. Semenova, et al.
Published: (2020-10-01) -
Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
by: Martina Bogeljić Patekar, et al.
Published: (2018-01-01) -
Herpetic Esophagitis Mimicking Carcinoma In Situ
by: Luiz Cesar Peres, et al.
Published: (2023-08-01)